Magnetic resonance molecular imaging of post-stroke neuroinflammation with a P-selectin targeted iron oxide nanoparticle

Contrast Media and Molecular Imaging

Volumn 4, Issue 6, 2009, Pages 305-311

  Jin, A Y ^a   Tuor, U I ^a,b   Rushforth, D ^b   Filfil, R ^b   Kaur, J ^a   Ni, F ^b   Tomanek, B ^a,b   Barber, P A ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Iron oxide; Magnetic resonance imaging; Nanoparticle; Neuroinflammation; P selectin; Stroke

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IRON DEXTRAN; IRON OXIDE; NANOPARTICLE; PADGEM PROTEIN; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG ACCUMULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMISPHERE; MALE; MOLECULAR IMAGING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STROKE;

ANIMALS; BRAIN; CONTRAST MEDIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FERRIC COMPOUNDS; IMMUNOHISTOCHEMISTRY; ISCHEMIC ATTACK, TRANSIENT; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; NANOPARTICLES; P-SELECTIN;

EID: 75149190604     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.292     Document Type: Article

References (29)

1. Johnston SC, Mendis S, Mathers CD. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol. 2009; 8: 345-354.
2. O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW. 1,026 experimental treatments in acute stroke. Ann. Neurol. 2006; 59: 467-477.
3. Blasberg RG, Tjuvajev JG. Molecular-genetic imaging: current and future perspectives. J. Clin. Invest. 2003; 111: 1620-1629.
4. Jasanoff A. Functional MRI using molecular imaging agents. Trends Neurosci. 2005; 28: 120-126.
5. Lanza GM, Winter PM, Caruthers SD, Morawski AM, Schmieder AH, Crowder KC, Wickline SA. Magnetic resonance molecular imaging with nanoparticles. J. Nucl. Cardiol. 2004; 11: 733-743.
6. Weissleder R, Mahmood U. Molecular imaging. Radiology 2001; 219: 316-333.
7. van Kasteren SI, Campbell SJ, Serres S, Anthony DC, Sibson NR, Davis BG. Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease. Proc. Natl Acad. Sci. USA 2009; 106: 18-23.
8. Sibson NR, Blamire AM, Bernades-Silva M, Laurent S, Boutry S, Muller RN, Styles P, Anthony DC. MRI detection of early endothelial activation in brain inflammation. Magn. Reson. Med. 2004; 51: 248-252.
9. Wang X, Jin PP, Zhou T, Zhao YP, Ding QL, Wang DB, Zhao GM, Dai J, Wang HL, Ge HL. MR Molecular imaging of thrombus: development and application of a Gd-based novel contrast agent targeting to P-selectin. Clin. Appl. Thromb. Hemost. 2009.
10. Boutry S, Burtea C, Laurent S, Toubeau G, Vander Elst L, Muller RN. Magnetic resonance imaging of inflammation with a specific selectin-targeted contrast agent. Magn. Reson. Med. 2005; 53: 800-807.
11. Barber PA, Foniok T, Kirk D, Buchan AM, Laurent S, Boutry S, Muller RN, Hoyte L, Tomanek B, Tuor UI. MR molecular imaging of early endothelial activation in focal ischemia. Ann. Neurol. 2004; 56: 116-120.
12. Atkinson C, Zhu H, Qiao F, Varela JC, Yu J, Song H, Kindy MS, Tomlinson S. Complement-dependent P-selectin expression and injury following ischemic stroke. J. Immunol. 2006; 177: 7266-7274.
13. Zhang R, Chopp M, Zhang Z, Jiang N, Powers C. The expression of P- and E-selectins in three models of middle cerebral artery occlusion. Brain Res. 1998; 785: 207-214.
14. Danton GH, Dietrich WD. Inflammatory mechanisms after ischemia and stroke. J. Neuropathol. Exp. Neurol. 2003; 62: 127-136.
15. Huang J, Upadhyay UM, Tamargo RJ. Inflammation in stroke and focal cerebral ischemia. Surg. Neurol. 2006; 66: 232-245.
16. Ishikawa M, Cooper D, Arumugam TV, Zhang JH, Nanda A, Granger DN. Platelet-leukocyte-endothelial cell interactions after middle cerebral artery occlusion and reperfusion. J. Cereb. Blood Flow Metab. 2004; 24: 907-915.
17. Ishikawa M, Cooper D, Russell J, Salter JW, Zhang JH, Nanda A, Granger DN. Molecular determinants of the prothrombogenic and inflammatory phenotype assumed by the postischemic cerebral microcirculation. Stroke 2003; 34: 1777-1782.
18. Bulte JW, Zhang S, van GP, Herynek V, Jordan EK, Duncan ID, Frank JA. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc. Natl Acad. Sci. USA 1999; 96: 15256-15261.
19. Guzman R, Bliss T, De Los AA, Moseley M, Palmer T, Steinberg G. Neural progenitor cells transplanted into the uninjured brain undergo targeted migration after stroke onset. J. Neurosci. Res. 2008; 86: 873-882.
20. Yang M, Christoforidis GA, Figueredo T, Heverhagen JT, Abduljalil A, Knopp MV. Dosage determination of ultrasmall particles of iron oxide for the delineation of microvasculature in the Wistar rat brain. Invest. Radiol. 2005; 40: 655-660.
21. von Zur MC, von ED, Choudhury RP, Ender J, Ahrens I, Schwarz M, Hennig J, Bode C, Peter K. Functionalized magnetic resonance contrast agent selectively binds to glycoprotein IIb/IIIa on activated human platelets under flow conditions and is detectable at clinically relevant field strengths. Mol. Imag. 2008; 7: 59-67.
22. Lehmberg J, Beck J, Baethmann A, Uhl E. Effect of P-selectin inhibition on leukocyte-endothelium interaction and survival after global cerebral ischemia. J. Neurol. 2006; 253: 357-363.
23. Ruehl ML, Orozco JA, Stoker MB, McDonagh PF, Coull BM, Ritter LS. Protective effects of inhibiting both blood and vascular selectins after stroke and reperfusion. Neurol. Res. 2002; 24: 226-232.
24. Suzuki H, Hayashi T, Tojo SJ, Kitagawa H, Kimura K, Mizugaki M, Itoyama Y, Abe K. Anti-P-selectin antibody attenuates rat brain ischemic injury. Neurosci. Lett. 1999; 265: 163-166.
25. Connolly ES Jr, Winfree CJ, Prestigiacomo CJ, Kim SC, Choudhri TF, Hoh BL, Naka Y, Solomon RA, Pinsky DJ. Exacerbation of cerebral injury in mice that express the P-selectin gene: identification of P-selectin blockade as a new target for the treatment of stroke. Circul. Res. 1997; 81: 304-310.
26. Molenaar TJ, Twisk J, de Haas SA, Peterse N, Vogelaar BJ, van Leeuwen SH, Michon IN, van Berkel TJ, Kuiper J, Biessen EA. P-selectin as a candidate target in atherosclerosis. Biochem. Pharmacol. 2003; 66: 859-866.
27. Perez-Trepichio AD, Furlan AJ, Little JR, Jones SC. Hydroxyethyl starch 200/0.5 reduces infarct volume after embolic stroke in rats. Stroke 1992; 23: 1782-1790.
28. Salgado AV, Jones SC, Furlan AJ, Korfali E, Marshall SA, Little JR. Bimodal treatment with nimodipine and low-molecular-weight dextran for focal cerebral ischemia in the rat. Ann. Neurol. 1989; 26: 621-627.
29. Hartree EF. Determination of protein: a modification of the Lowry method that gives a linear photometric response. Anal. Biochem. 1972; 48: 422-427.